{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:56:04Z","timestamp":1785495364032,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.02.013","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T08:25:56Z","timestamp":1581668756000},"page":"2671-2677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial"],"prefix":"10.1016","volume":"38","author":[{"given":"Qing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqaing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2020.02.013_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2017.6.1.4","article-title":"Enterovirus 71 infection and vaccines","volume":"6","author":"Yi","year":"2017","journal-title":"Clin Experim Vaccine Res"},{"key":"10.1016\/j.vaccine.2020.02.013_b0010","doi-asserted-by":"crossref","unstructured":"Huang J, Liao Q, Ooi MH, Cowling BJ, Chang Z, Wu P, et al. Epidemiology of recurrent hand, foot and mouth disease, China, 2008\u20132015. Emerg Infect Dis. 2018;24(3).","DOI":"10.3201\/eid2403.171303"},{"key":"10.1016\/j.vaccine.2020.02.013_b0015","unstructured":"Chinese Center for Disease Control and Prevention. Analysis of epidemic characteristics of hand, foot and mouth disease in China from 2009 to 2018. Infectious Diseases Report. 2019;7(1):17."},{"issue":"9","key":"10.1016\/j.vaccine.2020.02.013_b0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.vaccine.2014.10.081","article-title":"Considerations for developing an immunization strategy with enterovirus 71 vaccine","volume":"33","author":"Li","year":"2015","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.013_b0025","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.3390\/v7122949","article-title":"Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines","volume":"7","author":"Ng","year":"2015","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.013_b0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"9882","key":"10.1016\/j.vaccine.2020.02.013_b0035","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2020.02.013_b0040","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2020.02.013_b0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2020.02.013_b0050","unstructured":"Chinese Center for Disease Control and Prevention. Technical guidelines for the use of inactivated enterovirus 71 vaccines (2016). http:\/\/wwwchinacdccn\/zxdt\/201606\/t20160608_131032html. 2016."},{"issue":"22","key":"10.1016\/j.vaccine.2020.02.013_b0055","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","article-title":"Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial","volume":"30","author":"Li","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.013_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/infdis\/jit429","article-title":"Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial","volume":"209","author":"Li","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.013_b0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijid.2007.08.006","article-title":"Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children","volume":"12","author":"Abarca","year":"2008","journal-title":"Int J Infect Dis"},{"issue":"27","key":"10.1016\/j.vaccine.2020.02.013_b0070","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1016\/j.vaccine.2012.04.038","article-title":"Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children","volume":"30","author":"Zhang","year":"2012","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2020.02.013_b0075","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0264-410X(00)00301-7","article-title":"Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines","volume":"19","author":"Bryan","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.013_b0080","first-page":"35","article-title":"Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants","volume":"15","author":"Tregnaghi","year":"2004","journal-title":"Revista panamericana de salud publica = Pan American Journal of Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.013_b0085","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.1995.03520350031024","article-title":"Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants","volume":"273","author":"Anderson","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.013_b0090","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1542\/peds.98.5.898","article-title":"Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen","volume":"98","author":"Bewley","year":"1996","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.013_b0095","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2603","article-title":"Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules","volume":"137","author":"Libster","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.02.013_b0100","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz129","article-title":"Immunogenicity and safety of an inactivated enterovirus 71 vaccine administered simultaneously with recombinant hepatitis B vaccine and group A meningococcal polysaccharide vaccine: a phase IV, open-label, single-center, randomized, non-inferiority trial","author":"Zhang","year":"2019","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:57Z","timestamp":1759401597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20301869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X20301869"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}